Abbott’s HUMIRA® (adalimumab) approved in Europe for treatment of non-radiographic axial spondyloarthritis
The European Commission has approved HUMIRA®...
30 July 2012 | By Abbott
The European Commission has approved HUMIRA®...
List view / Grid view
The European Commission has approved HUMIRA®...
30 July 2012 | By Abbott
The European Commission has approved HUMIRA®...
First Phase 3 study to evaluate an anti-TNF in patients…
6 June 2012 | By Abbott
First Phase 3 study to evaluate an anti-TNF in patients with non-radiographic axial spondyloarthritis...